Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(8):633-634; doi:10.1093/jnci/djh099
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Galloway, D. A.
Right arrow Articles by Carter, J. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Galloway, D. A.
Right arrow Articles by Carter, J. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

RESPONSE: Re: Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans

Denise A. Galloway, Joseph J. Carter

Affiliation of authors: Fred Hutchinson Cancer Research Center, Seattle, WA

Correspondence to: Denise A. Galloway, PhD, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N, Rm. C1-105, P.O. Box 19024, Seattle, WA 98109-1024 (e-mail: dgallowa@fhcrc.org)

The first 10% of the full text of this article appears below.

We agree with Vilchez and Butel’s comments that serology is but one of several valid methods for examining the question of whether simian virus 40 (SV40) is circulating in the general population. The utility of polymerase chain reaction (PCR)-based methods for detecting SV40 . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?